Fed. Circ. Blocks Generic Sales Of AstraZeneca's Pulmicort
The Federal Circuit on Friday blocked four generic-drug makers from launching no-name versions of AstraZeneca PLC's Pulmicort Respules pediatric asthma medication while the pharmaceutical giant appeals a lower court ruling in...To view the full article, register now.
Already a subscriber? Click here to view full article